India finds engine switch movement in fatal Air India crash, no immediate action for Boeing or GE

Investigative officials stand at the site of Air India Boeing 787 which crashed yesterday, on June 13, 2025 in Ahmedabad, India.

Ritesh Shukla | Getty Images

A preliminary report by Indian aviation accident investigators said on Saturday the fatal Air India crash that killed 260 people in Ahmedabad last month showed the plane engines’ fuel switches shifting from run to cutoff within seconds of each other.

“At this stage of investigation, there are no recommended actions to Boeing and/or GE engine operators and manufacturers” India’s Aircraft Accident Investigation Bureau said.

The agency, an office under India’s civil aviation ministry, is leading the probe into the world’s deadliest aviation accident in a decade.

Source

World

Italy investigates Sephora and Benefit over skincare marketing to children

March 27, 2026

A view of a Sephora beauty product store on May 30, 2025 in Sherman Oaks, California. Justin Sullivan | Getty Images Italian regulators are looking to clamp down on the tween skincare obsession and are investigating the LVMH-owned cosmetic brands Sephora and Benefit over an “insidious” marketing campaign to children. The Italian Competition Authority (AGCM) […]

World

Economist Nouriel Roubini: Trump is likely to escalate the Iran war — risking ‘1970s stagflation’

March 27, 2026

U.S. President Donald Trump is likely to escalate the war with Iran, risking “1970s stagflation” if it does not go as planned, renowned economist and investor Nouriel Roubini told CNBC. Speaking to CNBC’s Carolin Roth at the Ambrosetti Forum in Cernobbio, Italy on Friday, Roubini — best known for predicting the 2008 Global Financial Crisis […]

World

AstraZeneca stock jumps after surprise trial win for lung disease drug where rivals have failed

March 27, 2026

AstraZeneca‘s stock jumped nearly 5% after Britain’s most valuable company said its experimental lung disease medicine met its target in two late-stage clinical trials. The respiratory treatment tozorakimab, reduced flare-ups of chronic obstructive pulmonary disease (COPD) in both former smokers and in the overall population versus placebo, the company said. “This marks a notable shift […]